Paxlovid
Access to Medicine
WIPO SCP 33: Statement of Knowledge Ecology International on patents and health
On Wednesday, 8 December 2021, Knowledge Ecology International (KEI) delivered the following statement on patents and health at the 33rd session of the WIPO Standing Committee on the Law of Patents (SCP). 8 December 2021 We take note of WIPO’s… Continue Reading
WIPO SCP 33: Opening statement of Asia and Pacific Group stresses that WIPO “ought to give primacy to the issues of Public Health and Transfer of Technology”
On Monday, 6 December 2021, India delivered an opening statement on behalf of the Asia and Pacific Group (AGP). The Islamic Republic of Iran, Bangladesh, Singapore, Indonesia, United Arab Emirates, and the Republic of Korea are just a few of… Continue Reading
KEI requests an open compulsory license relating to Paxlovid in the Dominican Republic
On Friday, December 3, 2021, KEI requested an open public interest license to allow the exploitation of PF-07321332 (marketed in combination with ritonavir under the brand Paxlovid) in the Dominican Republic. PF-07321332, being developed by Pfizer, has shown promising results… Continue Reading
Letter to Ambassador Tai at USTR regarding bilateral and plurilateral trade agreements and COVID 19
USTR-AmbTai-Bilateral-Plurilateal-agreements-3Dec2021 December 3, 2021 Ambassador Katherine Tai Office of the United States Trade Representative Washington, DC Dear Ambassador Tai, On November 18, 2021, Knowledge Ecology International (KEI) provided comments to USTR on three issues that were important for any WTO… Continue Reading
KEI Statement on the WHO decision to begin negotiations on a pandemic treaty
The World Health Assembly’s adoption of a decision [link] to launch intergovernmental negotiations on a WHO pandemic treaty signaled the intent of WHO member states to consider deep consequential reforms in the global pandemic response. KEI is among those who… Continue Reading
Special Session of the World Health Assembly: Statement of Knowledge Ecology International
On Tuesday, 30 November 2021, Knowledge Ecology International (KEI) delivered the following statement during the special session of the World Health Assembly. Negotiators should address policy failures that have accompanied the current pandemic response, and create a better global framework… Continue Reading
WTO accession agreements and a TRIPS waiver for COVID 19 (such as China’s six years of exclusive rights in regulatory test data)
On October 1, 2001, the World Trade Organization (WTO) issued a “Report of the Working Party on the Accession of China.” The 180 page document (WT/ACC/CHN/49) included a discussion of the views of “some members” of the WTO regarding the… Continue Reading
WHO member countries agree on a pathway to draft and negotiate a convention, agreement or other international instrument on pandemic prevention, preparedness and response
After two weeks of intense negotiations, member states of the World Health Organization (WHO) have finally agreed to compromise text on a decision (The World Together: Establishment of an intergovernmental negotiating body to strengthen pandemic prevention, preparedness and response, SSA2/CONF./1)… Continue Reading
KEI letter to USTR on TRIPS waiver negotiations highlights the three issues
KEI sent this letter to USTR today regarding the TRIPS Waiver negotiations. Highlights what we think are the three most important issues. KEI-USTR-TRIPS-waiver-Priorities-18nov2021 November 18, 2021 Ambassador Katherine Tai Office of the United States Trade Representative Washington, DC Dear Ambassador… Continue Reading